Answer to Question 1
1,3
Rationale 1: An overdose of phenylephrine (Neo-Synephrine) will result in tachycardia.
Rationale 2: Feelings of anxiety and restlessness are expected adverse effects of phenylephrine (Neo-Synephrine).
Rationale 3: Overdosage of phenylephrine (Neo-Synephrine) will result in hypertension.
Rationale 4: Dark and tarry stools are not related to phenylephrine (Neo-Synephrine).
Rationale 5: Burning at the injection site would indicate possible extravasation, not overdose.
Global Rationale: An overdose of phenylephrine (Neo-Synephrine) will result in tachycardia and hypertension. Feelings of anxiety and restlessness are expected adverse effects of phenylephrine (Neo-Synephrine). Dark and tarry stools are not related to phenylephrine (Neo-Synephrine). Burning at the injection site would indicate possible extravasation, not overdose.
Answer to Question 2
2,3
Rationale 1: There is no particular reason that bowel sounds should be monitored more frequently than normally done.
Rationale 2: Clevidipine (Cleviprex) is administered intravenously.
Rationale 3: Clevidipine (Cleviprex) has an ultrashort half-life so blood pressure will be monitored continuously.
Rationale 4: This drug is not supplied in caplet form.
Rationale 5: Infusing normal saline at this rate would be contraindicated in hypertensive emergency.
Global Rationale: Clevidipine (Cleviprex) is administered intravenously. It has an ultrashort half-life so blood pressure will be monitored continuously. There is no particular reason that bowel sounds should be monitored more frequently than normally done. This drug is not supplied in caplet form. Infusing normal saline at this rate would be contraindicated in hypertensive emergency.